The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis
Open accessAbstract
BACKGROUND: The physiopathology of sepsis continues to be poorly understood, and despite recent advances in its management, sepsis is still a life-threatening condition with a poor outcome. If new diagnostic markers related to sepsis pathogenesis will be identified, new specific therapies might be developed and mortality reduced. Small regulatory non-coding RNAs, microRNAs (miRNAs), were recently linked to various diseases; the aim of our prospective study was to identify miRNAs that can differentiate patients with early-stage sepsis from healthy controls and to determine if miRNA levels correlate with the severity assessed by the Sequential Organ Failure Assessment (SOFA) score. METHODOLOGY/PRINCIPAL FINDINGS: By using genome-wide miRNA profiling by microarray in peripheral blood leukocytes, we found that miR-150, miR-182, miR-342-5p, and miR-486 expression profiles differentiated sepsis patients from healthy controls. We also proved by quantitative reverse transcription-polymerase chain reaction that miR-150 levels were significantly reduced in plasma samples of sepsis patients and correlated with the level of disease severity measured by the SOFA score, but were independent of the white blood counts (WBC). We found that plasma levels of tumor necrosis factor alpha, interleukin-10, and interleukin-18, all genes with sequence complementarity to miR-150, were negatively correlated with the plasma levels of this miRNA. Furthermore, we identified that the plasma levels ratio for miR-150/interleukin-18 can be used for assessing the severity of the sepsis. CONCLUSIONS/SIGNIFICANCE: We propose that miR-150 levels in both leukocytes and plasma correlate with the aggressiveness of sepsis and can be used as a marker of early sepsis. Furthermore, we envision miR-150 restoration as a future therapeutic option in sepsis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Self-citationThe Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364 · cited 1×
“As it is well known that IL-10 and TNF-alpha play an important role in immune response and are dysregulated in sepsis patients [24,25], we checked by using an additional target prediction program (RNA22) to identify possible regions of interaction with miR-150.”
MethodTili, E., Michaille, J.-J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., Fabbri, M., Alder, H., Liu, C. G., Calin, G. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5082 · Cited by 1,304 · cited 3×
“7 mouse macrophages [13], were not statistically significant dysregulated in the analyzed set of patients.”
BackgroundInfluentialSelf-citationDombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,249
MicroRNAs: new regulators of immune cell development and function
Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S., & Taganov, K. D. (2008) · Nature Immunology · doi:10.1038/ni.f.209 · Cited by 1,088
MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb
Xiao, C., Calado, D. P., Galler, G., Thai, T.-H., Patterson, H. C., Wang, J., Rajewsky, N., Bender, T. P., & Rajewsky, K. (2007) · Cell · doi:10.1016/j.cell.2007.07.021 · Cited by 1,042
Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6952 · Cited by 934
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.012 · Cited by 801 · cited 1×
“known to be involved in sepsis (Table 2): MAPK inhibition improves survival in endotoxin shock and prevents sepsis [18]; Wnt has a role in regulation of inflammation [19]; and insulin resistance [20,21], ErbB (EGFR) [22], and mTOR [23] are related to immune and inflammatory response.”
BackgroundApoptosis and caspases regulate death and inflammation in sepsis
Hotchkiss, R. S., & Nicholson, D. W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1943 · Cited by 795
MicroRNAs — the micro steering wheel of tumour metastases
Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S., & Calin, G. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2619 · Cited by 749
Self-citationPerkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574 · cited 1×
“Recently, a new category of non-coding RNAs (RNAs that do not codify for proteins), named microRNAs (miRNAs), was found to be involved in the initiation, progression, and metastasis of any type of analyzed human cancer [6,7]; miRNAs also play a role in other diseases, such as schizophrenia [8], diabetes [9], inflammat…”
BackgroundEvaluation of SOFA-based models for predicting mortality in the ICU: A systematic review
Minne, L., Abu-Hanna, A., & de Jonge, E. (2008) · Critical Care · doi:10.1186/cc7160 · Cited by 547
Wu, F., Zikusoka, M., Trindade, A., Dassopoulos, T., Harris, M. L., Bayless, T. M., Brant, S. R., Chakravarti, S., & Kwon, J. H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.068 · Cited by 508
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
Cortez, M. A., & Calin, G. A. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902932889 · Cited by 436
Self-citationWang, Q., Wang, Y., Minto, A. W., Wang, J., Shi, Q., Li, X., & Quigg, R. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-112326 · Cited by 397
Depletion of Dendritic Cells, But Not Macrophages, in Patients with Sepsis
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Grayson, M. H., Osborne, D. F., Wagner, T. H., Cobb, J. P., Coopersmith, C., & Karl, I. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2493 · Cited by 385
MicroRNA expression profiles predictive of human renal allograft status
Anglicheau, D., Sharma, V. K., Ding, R., Hummel, A., Snopkowski, C., Dadhania, D., Seshan, S. V., & Suthanthiran, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813121106 · Cited by 337
Pereira, C., Schaer, D. J., Bachli, E. B., Kurrer, M. O., & Schoedon, G. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.157438 · Cited by 318
Koff, J. L., Shao, M. X. G., Ueki, I. F., & Nadel, J. A. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00025.2008 · Cited by 226
Fredriksson, K., Tjäder, I., Keller, P., Petrovic, N., Ahlman, B., Schéele, C., Wernerman, J., Timmons, J. A., & Rooyackers, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003686 · Cited by 170
In vivo profile of the human leukocyte microRNA response to endotoxemia
Schmidt, W. M., Spiel, A. O., Jilma, B., Wolzt, M., & Müller, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.190 · Cited by 120
Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery
Hutchins, R., Gunning, M. P., Lucas, D. N., Allen-Mersh, T. G., & Soni, N. C. (2004) · World Journal of Surgery · doi:10.1007/s00268-003-7067-8 · Cited by 117
George, S. J. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.160952 · Cited by 105
Expression and function of micro RNAs in immune cells during normal or disease state
Tili, E., Michaille, J., & Calin, G. A. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.73 · Cited by 105
Self-citationLibert, C. (2003) · Nature · doi:10.1038/421328a · Cited by 96 · cited 1×
“Total mortality for patients with acute postoperative sepsis is about 30%–35%; however, the mortality rate for patients with severe sepsis is over 50% [1,26].”
BackgroundElevation of IL-18 in Human Sepsis
Grobmyer, S. R., Lin, E., Lowry, S. F., Rivadeneira, D. E., Potter, S. H., Barie, P. S., & Nathan, C. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1006641630904 · Cited by 92
Abe, R., Hirasawa, H., Oda, S., Sadahiro, T., Nakamura, M., Watanabe, E., Nakada, T., Hatano, M., & Tokuhisa, T. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.07.009 · Cited by 47
Lichtenstern, C., Schmidt, J., Knaebel, H., Martin, E., Büchler, M. W., & Weigand, M. A. (2007) · Digestive Surgery · doi:10.1159/000099009 · Cited by 28
Insulin therapy induces changes in the inflammatory response in a murine 2-hit model
Barkhausen, T., Probst, C. P., Hildebrand, F., Pape, H., Krettek, C., & van Griensven, M. (2009) · Injury · doi:10.1016/j.injury.2008.07.018 · Cited by 21
Insulin Resistance and β Cell Function As Prognostic Indicator in Multi-Organ Dysfunction Syndrome
Das, S., Misra, B., Roul, L., Minz, N. T., Pattnaik, M., & Baig, M. A. A. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0025 · Cited by 20
Cited by
MicroRNAs in body fluids—the mix of hormones and biomarkers
Cortez, M. A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A. K., & Calin, G. A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.76 · Cited by 1,465
Self-citationmiRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,344
Future threats to biodiversity and pathways to their prevention
Tilman, D., Clark, M., Williams, D. R., Kimmel, K., Polasky, S., & Packer, C. (2017) · Nature · doi:10.1038/nature22900 · Cited by 1,341
Non-coding RNAs in disease: from mechanisms to therapeutics
Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-023-00662-1 · Cited by 885
Self-citationCirculating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease
Corsten, M. F., Dennert, R., Jochems, S., Kuznetsova, T., Devaux, Y., Hofstra, L., Wagner, D. R., Staessen, J. A., Heymans, S., & Schroen, B. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.957415 · Cited by 794
Metadata
- Authors
- Vasilescu, C., Rossi, S., Shimizu, M., Tudor, S., Veronese, A., Ferracin, M., Nicoloso, M. S., Barbarotto, E., Popa, M., Stanciulea, O., Fernandez, M. H., Tulbure, D., Bueso-Ramos, C. E., Negrini, M., & Calin, G. A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-10-12
- Volume
- 4
- Issue
- 10
- Pages
- e7405
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2043973101
- Cited by
- 354
- References
- 33
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.